| 51.05 Data as of May 17 |  -0.23 / -0.45%Today’s Change | 29.92 Today|||52-Week Range 53.08 | +16.15% Year-to-Date |
| Previous close | 51.28 |
| Today’s open | 50.72 |
| Day’s range | 50.67 - 51.05 |
| Volume | 1,913 |
| Average volume (3 months) | 4,001 |
| Market cap | $9.9B |
| Dividend yield | 1.46% |
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +6.55% |
| Revenue growth (last year) | -- |
| P/E ratio | -- |
| Price/Sales | -- |
| Price/Book | -- |
| No competitors data available. |
| Last reporting date | May 14, 2013 |
| EPS forecast (this quarter) | $0.87 |
| Annual revenue (last year) | -- |
| Annual profit (last year) | -- |
| Net profit margin | -- |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters --, -- |
.
